JP2011528895A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011528895A5 JP2011528895A5 JP2011519185A JP2011519185A JP2011528895A5 JP 2011528895 A5 JP2011528895 A5 JP 2011528895A5 JP 2011519185 A JP2011519185 A JP 2011519185A JP 2011519185 A JP2011519185 A JP 2011519185A JP 2011528895 A5 JP2011528895 A5 JP 2011528895A5
- Authority
- JP
- Japan
- Prior art keywords
- protein sequence
- prevention
- rv3616c protein
- treatment
- latent tuberculosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8372008P | 2008-07-25 | 2008-07-25 | |
| US61/083,720 | 2008-07-25 | ||
| PCT/EP2009/059580 WO2010010177A1 (en) | 2008-07-25 | 2009-07-24 | Novel compositions and methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011528895A JP2011528895A (ja) | 2011-12-01 |
| JP2011528895A5 true JP2011528895A5 (OSRAM) | 2012-09-06 |
| JP5873332B2 JP5873332B2 (ja) | 2016-03-01 |
Family
ID=41217660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011519185A Expired - Fee Related JP5873332B2 (ja) | 2008-07-25 | 2009-07-24 | 新規化合物および方法 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US20110117119A1 (OSRAM) |
| EP (1) | EP2315773B1 (OSRAM) |
| JP (1) | JP5873332B2 (OSRAM) |
| KR (1) | KR20110044883A (OSRAM) |
| CN (1) | CN102164952B (OSRAM) |
| AU (1) | AU2009273130B2 (OSRAM) |
| BR (1) | BRPI0916703A2 (OSRAM) |
| CA (1) | CA2731499C (OSRAM) |
| CO (1) | CO6341637A2 (OSRAM) |
| CY (1) | CY1118200T1 (OSRAM) |
| DK (1) | DK2315773T3 (OSRAM) |
| EA (1) | EA024826B1 (OSRAM) |
| ES (1) | ES2602430T3 (OSRAM) |
| HR (1) | HRP20161458T1 (OSRAM) |
| HU (1) | HUE031044T2 (OSRAM) |
| IL (1) | IL210559A0 (OSRAM) |
| LT (1) | LT2315773T (OSRAM) |
| MX (1) | MX2011000983A (OSRAM) |
| PL (1) | PL2315773T3 (OSRAM) |
| PT (1) | PT2315773T (OSRAM) |
| SG (1) | SG192456A1 (OSRAM) |
| SI (1) | SI2315773T1 (OSRAM) |
| UA (1) | UA107330C2 (OSRAM) |
| WO (1) | WO2010010177A1 (OSRAM) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1350546A (zh) * | 1998-11-04 | 2002-05-22 | Isis创新有限公司 | 结核诊断测验 |
| EP2315597B1 (en) | 2008-07-25 | 2017-08-23 | GlaxoSmithKline Biologicals S.A. | Novel compositions and methods |
| WO2010010179A1 (en) | 2008-07-25 | 2010-01-28 | Glaxosmithkline Biologicals S.A. | The tuberculosis rv2386c protein, compositions and uses thereof |
| EP2156945A1 (en) | 2008-08-13 | 2010-02-24 | Novelis Inc. | Clad automotive sheet product |
| CN102413837B (zh) | 2009-04-24 | 2015-11-25 | 国立血清研究所 | 预防再激活的结核病tb疫苗 |
| PL2528621T3 (pl) | 2010-01-27 | 2017-07-31 | Glaxosmithkline Biologicals S.A. | Zmodyfikowane antygeny gruźlicy |
| CN105765592B (zh) | 2013-09-27 | 2019-12-17 | 科德克希思公司 | 用于酶变体的自动筛选的方法、装置和系统 |
| JP6309086B2 (ja) * | 2013-09-27 | 2018-04-11 | コデクシス， インコーポレイテッド | 構造ベース予測モデリング |
| GB201405921D0 (en) * | 2014-04-02 | 2014-05-14 | Glaxosmithkline Biolog Sa | Novel methods for inducing an immune response |
| CN106546737A (zh) * | 2016-10-24 | 2017-03-29 | 广州迪澳医疗科技有限公司 | 一种体外检测活动性结核的方法 |
| GB201621686D0 (en) | 2016-12-20 | 2017-02-01 | Glaxosmithkline Biologicals Sa | Novel methods for inducing an immune response |
| GB201707700D0 (en) | 2017-05-12 | 2017-06-28 | Glaxosmithkline Biologicals Sa | Dried composition |
| FR3066920A1 (fr) | 2017-05-30 | 2018-12-07 | Glaxosmithkline Biologicals S.A. | Nouveaux procedes de fabrication d'un adjuvant |
| WO2019106192A1 (en) | 2017-12-01 | 2019-06-06 | Glaxosmithkline Biologicals Sa | Saponin purification |
| KR20210152515A (ko) | 2019-04-12 | 2021-12-15 | 씨4 테라퓨틱스, 인코포레이티드 | 이카로스 및 아이올로스의 트리시클릭 분해제 |
| CA3142300C (en) | 2019-06-05 | 2025-02-04 | Glaxosmithkline Biologicals Sa | SAPONIN PURIFICATION |
| CN115073612B (zh) * | 2022-06-22 | 2024-09-27 | 宁夏大学 | 一种结核分枝杆菌Zera-71cA蛋白纳米颗粒、制备方法及其用途 |
| GB202318595D0 (en) * | 2023-12-05 | 2024-01-17 | Sec Dep For Environment Food And Rural Affairs Acting Through Animal And Plant Health Agency | Diagnostic proteins and reagents |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6613881B1 (en) * | 1997-05-20 | 2003-09-02 | Corixa Corporation | Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| WO1999051748A2 (en) * | 1998-04-07 | 1999-10-14 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| AU2001241738A1 (en) * | 2000-02-25 | 2001-09-03 | Corixa Corporation | Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| AU6867801A (en) * | 2000-06-20 | 2002-01-02 | Corixa Corp | Fusion proteins of mycobacterium tuberculosis |
| CA2433236C (en) * | 2001-01-08 | 2016-10-04 | Isis Innovation Limited | Assay to determine efficacy of treatment for m. tuberculosis infection |
| CN1277843C (zh) * | 2001-02-22 | 2006-10-04 | 巴斯德研究院 | 分枝杆菌比较基因组学作为鉴定分枝杆菌病的诊断、预防或治疗靶的工具 |
| US20030236393A1 (en) * | 2002-03-22 | 2003-12-25 | United States Of America Dept Of Vetrans Affairs | Virulence genes of M. marinum and M. tuberculosis |
| EP2226332A1 (en) * | 2004-06-17 | 2010-09-08 | Beckman Coulter, Inc. | Mycobacterium tuberculosis epitopes and methods of use thereof |
| PL2457926T3 (pl) | 2005-04-29 | 2015-03-31 | Glaxosmithkline Biologicals Sa | Nowy sposób profilaktyki lub leczenia zakażenia m. tuberculosis |
| AU2006261445B2 (en) * | 2005-06-23 | 2011-03-31 | Statens Serum Institut | Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
| WO2008007942A1 (en) * | 2006-07-10 | 2008-01-17 | Het Nederlands Kanker Instituut | Means and methods for manipulating sequential phagolysomal-cytosolic translocation of mycobacteria, and uses thereof |
| EP2368568A1 (en) * | 2006-11-01 | 2011-09-28 | Immport Therapeutics, INC. | Compositions and methods for immunodominant antigens |
| CN102413837B (zh) * | 2009-04-24 | 2015-11-25 | 国立血清研究所 | 预防再激活的结核病tb疫苗 |
| PL2528621T3 (pl) | 2010-01-27 | 2017-07-31 | Glaxosmithkline Biologicals S.A. | Zmodyfikowane antygeny gruźlicy |
-
2009
- 2009-07-24 UA UAA201100363A patent/UA107330C2/uk unknown
- 2009-07-24 SG SG2013050562A patent/SG192456A1/en unknown
- 2009-07-24 LT LTEP09781052.7T patent/LT2315773T/lt unknown
- 2009-07-24 US US13/055,801 patent/US20110117119A1/en not_active Abandoned
- 2009-07-24 HR HRP20161458TT patent/HRP20161458T1/hr unknown
- 2009-07-24 CA CA2731499A patent/CA2731499C/en active Active
- 2009-07-24 CN CN200980138400.6A patent/CN102164952B/zh active Active
- 2009-07-24 AU AU2009273130A patent/AU2009273130B2/en not_active Ceased
- 2009-07-24 HU HUE09781052A patent/HUE031044T2/en unknown
- 2009-07-24 BR BRPI0916703A patent/BRPI0916703A2/pt not_active IP Right Cessation
- 2009-07-24 ES ES09781052.7T patent/ES2602430T3/es active Active
- 2009-07-24 WO PCT/EP2009/059580 patent/WO2010010177A1/en not_active Ceased
- 2009-07-24 PT PT97810527T patent/PT2315773T/pt unknown
- 2009-07-24 SI SI200931561A patent/SI2315773T1/sl unknown
- 2009-07-24 PL PL09781052T patent/PL2315773T3/pl unknown
- 2009-07-24 JP JP2011519185A patent/JP5873332B2/ja not_active Expired - Fee Related
- 2009-07-24 DK DK09781052.7T patent/DK2315773T3/en active
- 2009-07-24 KR KR1020117004640A patent/KR20110044883A/ko not_active Ceased
- 2009-07-24 MX MX2011000983A patent/MX2011000983A/es active IP Right Grant
- 2009-07-24 EA EA201100072A patent/EA024826B1/ru not_active IP Right Cessation
- 2009-07-24 EP EP09781052.7A patent/EP2315773B1/en active Active
-
2011
- 2011-01-11 IL IL210559A patent/IL210559A0/en unknown
- 2011-01-27 CO CO11009231A patent/CO6341637A2/es not_active Application Discontinuation
-
2013
- 2013-06-28 US US13/930,587 patent/US9795663B2/en not_active Expired - Fee Related
-
2016
- 2016-11-04 CY CY20161101131T patent/CY1118200T1/el unknown